Viewing Study NCT06495593

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-05-05 @ 2:40 PM
Study NCT ID: NCT06495593
Status: RECRUITING
Last Update Posted: 2025-02-12
First Post: 2024-07-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
Sponsor: University of California, San Francisco
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis, Relapsing-Remitting View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ocrelizumab View
None Lymph node View
None Lymphocyte View